Objectives: We aimed to report the first 54 cases of pregnant women infected by Zika virus (ZIKV) and their virologic and clinical outcomes, as well as their newborns' outcomes, in 2016, after the emergence of ZIKV in dengue-endemic areas of São Paulo, Brazil. Methods: This descriptive study was performed from February to October 2016 on 54 quantitative realtime PCR ZIKV-positive pregnant women identified by the public health authority of São Jos e do Rio Preto, São Paulo, Brazil. The women were followed and had clinical and epidemiologic data collected before and after birth. Adverse outcomes in newborns were analysed and reported. Urine or blood samples from newborns were collected to identify ZIKV infection by reverse transcription PCR (RT-PCR). Results: A total of 216 acute Zika-suspected pregnant women were identified, and 54 had the diagnosis confirmed by RT-PCR. None of the 54 women miscarried. Among the 54 newborns, 15 exhibited adverse outcomes at birth. The highest number of ZIKV infections occurred during the second and third trimesters. No cases of microcephaly were reported, though a broad clinical spectrum of outcomes, including lenticulostriate vasculopathy, subependymal cysts, and auditory and ophthalmologic disorders, were identified. ZIKV RNA was detected in 18 of 51 newborns tested and in eight of 15 newborns with adverse outcomes. Conclusions: Although other studies have associated many newborn outcomes to ZIKV infection during pregnancy, these same adverse outcomes were rare or nonexistent in this study. The clinical presentation the newborns we studied was mild compared to other reports, suggesting that there is significant heterogeneity in congenital Zika infection. M.L. Nogueira, Clin Microbiol Infect 2018;▪:1
Introduction
Zika virus (ZIKV) infection has been associated with severe birth defects, such as newborn microcephaly [1, 2] , meningoencephalitis [3] and Guillain-Barr e syndrome (http://ecdc.europa.eu/ en/publications/Publications/zika-virus-americas-association-withmicrocephaly-rapid-risk-assessment.pdf) [4] . Microcephaly represents a small part of a broad spectrum of teratogenic outcomes of intrauterine ZIKV infection referred to as congenital Zika syndrome [5] . Intrauterine growth restriction, ocular abnormalities, placental damage, foetal blood anomalies [6] and death are other findings that may be associated with ZIKV infection during pregnancy [1, 2, 7] .
The city of São Jos e do Rio Preto in São Paulo State, Brazil, is a region in which several arbovirus circulate [8e10] . In 2016 a ZIKV outbreak was reported in the city [11] , and a surveillance system was established to identify illnesses caused by ZIKV. Special attention has been paid to pregnant women in an attempt to ascertain the impact of ZIKV infection on newborns. This study is a report of the first 54 confirmed cases of women infected by ZIKV during pregnancy and their virologic and clinical outcomes, as well as their newborns' outcomes, identified through our surveillance system.
Methods

Study population
From February to October 2016, the city's public health authority identified 216 pregnant patients with Zika-like symptoms among 1674 pregnant women receiving elective and emergency services. The Brazilian Ministry of Health defines Zika-suspected cases on the basis of macular or papular rash with two or more of the following signs or symptoms: fever, conjunctival hyperaemia without secretion, pruritus, polyarthralgia or joint oedema [12] . Fifty-seven pregnant women with symptomatic acute Zikasuspected infection between 5 and 38 weeks of pregnancy (gestational age defined as first trimester until week 13, second trimester from weeks 14 to 26, and third trimester after week 27) [13] who attended a health service in São Jos e do Rio Preto were considered to be Zika-suspected patients and had a blood sample collected during acute infection which was found to be ZIKV RT-PCR positive. These pregnant women were referred to the Children's and Maternity Hospital in São Jos e do Rio Preto, São Paulo, Brazil, the reference hospital, and were monitored under a protocol approved by the São Jos e do Rio Preto medical school institutional review board. These blood samples were also tested for toxoplasmosis, other agents (including HIV, when relevant), rubella, cytomegalovirus, herpes simplex, and syphilis (TORCHS) using molecular and/ or serologic methods. The ZIKV-positive pregnant women were monitored by a multidisciplinary medical team through the use of clinical and radiologic evaluations.
After delivery, the newborn's umbilical cord blood and/or urine were collected and tested for the presence of ZIKV by molecular and serologic methods. The clinical examinations of newborn and anthropometric measurements were performed according to the guidelines of the Brazilian Ministry of Health [12] , including definition of microcephaly, as newborns of 37 weeks' gestation or less and cephalic perimeter lower than 2 standard deviations (based on INTERGROWTH-21st Project data) for gestational age and sex [14] ; or newborns of 37 weeks' gestation or more and cephalic perimeter of less than or equal to 31.5 cm for girls and 31.9 cm for boys, and equivalent to lower than 2 standard deviations (based on World Health Organization criteria) [15] . The following were considered to be adverse outcomes: lenticulostriate vasculopathy, subependymal cysts, choroidal cyst, bilateral cranial bleed, chorioretinitis, premature birth and abnormal otoacoustic emission (OAE).
Ultrasounds were performed with an HDI 5000 convex probe (Philips, Amsterdam, The Netherlands) in order to generate foetal and postnatal images. Magnetic resonance imaging was performed with a Philips Gyroscan Intera 1.5 T scanner, and the images were analysed by specialists in foetal medicine. Special attention was given to the foetus's or newborn's central nervous system. When available, OAE tests and fundus examinations were performed by specialists to identify any auditory or ophthalmologic disorders, respectively.
Virus and RNA extraction
The virus strain used as positive control was ZIKV BR 
ZIKV quantitative real-time PCR
To detect the ZIKV genome in mothers' blood or newborns' umbilical cord blood and/or urine samples, a one-step quantitative real-time, fluorescent probe-based RT-PCR (qPCR) assay was performed using primers targeting the envelop (E) gene [18] . All samples with C t values of 38.5 or less were considered positive for ZIKV.
ZIKV ELISA
The umbilical cord blood samples found to be positive for ZIKV in qPCR were also tested for the Zika NS1 protein. The Zika Virus NS1 ELISA Kit (BioFront Technologies, Tallahassee, FL, USA) was used to capture anti-ZIKV NS1. All of the assays were performed according to the manufacturer's instructions. Each plate was read at 450 nm using a Spectramax Plus Microplate reader (Molecular Devices, Sunnyvale, CA, USA).
Complete genome
After RNA extraction, cDNA was synthesized using the High Capacity cDNA Reverse Transcription kit (Applied Biosystems; Thermo Fisher Scientific, Waltham, MA, USA). Nineteen fragments were amplified by nested PCR using Phusion high-fidelity DNA polymerase (Thermo Fisher Scientific). Fragment sizes ranged from 430 to 1461 bp. Nested PCR products were purified using the DNA Clean & Concentrator Kit (Zymo Research, Irvine, CA, USA). Fragments were sequenced using the direct Sanger method with BigDye Terminator 3.1 in an ABI 3130XL Genetic Analyzer (Applied Biosystems). Sequences were assembled and analysed for coverage and quality by SeqMan software from the Lasergene package (DNASTAR, Madison, WI, USA).
Phylogenetic reconstruction
The evolutionary history was inferred using the maximum likelihood method based on the general time reversible model [19] using a data set compiled of 99 complete open reading frame nucleotide sequences available in GenBank. The tree with the highest log likelihood (À35779.2777) is shown in Supplementary  Fig. S1 . The percentage of trees in which the associated taxa clustered together is shown next to the branches. Initial trees for the heuristic search were obtained automatically by applying the Neighbor-Join and BioNJ algorithms to a matrix of pairwise distances estimated using the maximum composite likelihood approach and then selecting the topology with superior log likelihood value. A discrete gamma distribution was used to model differences in evolutionary rates among sites (five categories; þG, parameter ¼ 0.2918). The rate variation model allowed for some sites to be evolutionarily invariable ([þI], 0.0010% sites). The tree is drawn to scale, with branch lengths measured in the number of substitutions per site. Codon positions included were 1 þ 2 þ 3 þ noncoding. All positions containing gaps and missing data were eliminated. There were a total of 10,208 positions in the final data set. Evolutionary analyses were conducted in MEGA7 [20] .
Statistical analysis
All statistical analyses were carried out using the Epi Info software for Windows (Centers for Disease Control and Prevention, Atlanta, GA, USA). We used chi-square and Wilcoxon rank sum tests to compare the characteristics according to birth outcomes for categorical and continuous data, respectively.
Results
Among 216 symptomatic acute ZIKV-suspected pregnant women in the São Jos e do Rio Preto public health system between February 2016 and October 2016, this descriptive study included 57 pregnant women (26%) who had ZIKV infection confirmed by RT-PCR in blood. Three pregnant women (5%) were lost to follow-up, resulting in a final sample size of 54 women. ZIKV infection was detected in all trimesters of gestation. Fifteen pregnant women (28%) experienced adverse birth outcomes. The clinical and demographic characteristics of the 54 mothers and their respective newborns are shown in Table 1 . The distribution of suspected and confirmed cases of ZIKV according to epidemiologic week and gestational week of ZIKV exposure as well as the associations between these data and adverse outcomes are shown in Figs 1 and 2 .
No pregnant woman in this study miscarried, and only eight (15%) of the foetuses were born at less than 37 weeks' gestation. The Apgar score median of the newborns was 9 of 10 and 10 of 10 at 1 and 5 minutes, respectively; two newborns had Apgar scores lower than 7 at 1 minute and none at 5 minutes, and no abnormalities were detected in the neurologic examinations. The additional serologic screening performed for infectious diseases during pregnancy is shown in Table 1 and Supplementary Table S4 . Findings of radiologic examinations are shown in Tables 1 and 2 .
Almost a quarter of pregnant women (28%, 15/54) who received follow-up care presented adverse foetal/birth outcomes (Supplementary Table S1 ). In three cases (20%) there were histories of comorbidities, and in seven cases the mother reported exposure to alcohol, tobacco or illicit drugs (Table 1 and Supplementary  Table S1 ). One newborn, born prematurely, encountered all of the anthropometric parameters below those expected for gestational age, compatible with intrauterine growth restriction. In this same newborn, unilateral ultrasound, abnormal OAE test results and ZIKV in cord blood (RT-PCR) were all identified, without other 
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infectious agents but with exposure to illicit drugs (marijuana) during gestation. The adverse outcomes observed in each case of ZIKV exposure in utero are listed in Supplementary Tables S1eS3.
Among the 39 newborns with no adverse birth outcomes, the profile of ZIKV exposure was similar to those with adverse outcomes. Clinical and laboratory data of these newborns are presented in Table 2 . The serologic and molecular tests for ZIKV are shown in Supplementary Table S6 .
Evidence of ZIKV infection was detected in 18 (35%) of 51 newborns who were evaluated by RT-PCR at birth using umbilical cord blood and/or urine samples (Table 3) . Among the newborns who did not exhibit adverse outcomes, ZIKV RNA was detected in ten (28%) of 36 (Supplementary Tables S4e7). The complete genome of ZIKV was amplified from one patient and two controls, all adult men, and sequenced. Phylogenetic analyses revealed that the ZIKV identified in our mothers during the 2016 outbreak was clustered together with the same virus circulating in other areas of the country (Supplementary Fig. S1 ).
Discussion
On the basis of surveillance alerts, our health centre has been conducting a prospective study on ZIKV in pregnancy and associated birth defects (with a focus on microcephaly) since January 2016. In ten months of surveillance, there were 216 cases of ZIKVsuspected pregnant women in our centre, and here we report 54 cases (26%) of pregnant women who were found to have ZIKV infection confirmed by RT-PCR in blood samples. Fifteen adverse foetal/birth outcomes and 18 cases of congenital ZIKV infection in newborns were reported. Although ZIKV infection in the first trimester of gestation is associated with microcephaly [1, 2] , no such cases have been detected thus far among the newborns in our cohort. Most of the adverse neurologic outcomes (14/15, 94%) occurred in the second and third trimesters, and this may have been responsible for these mild outcomes. This is not the first report to associate ZIKV infection after the first trimester with regular head circumference at birth but with adverse clinical outcomes, such as congenital brain injury acquired as a result of ZIKV [21] . The outcomes associated with ZIKV infection during pregnancy may include no effects, miscarriage or foetal infection resulting in congenital Zika syndrome [22] . An important study performed in Brazil in 2016 [1] reported several outcomes in foetuses and newborns exposed to ZIKV during pregnancy, as intrauterine growth restriction, cerebral calcifications, abnormal arterial flow in the cerebral or umbilical arteries, global cerebral atrophy, microcephaly, macular hypoplasia and scarring, and placental insufficiency.
Congenital anomalies, including microcephaly, have a complex and multifactorial aetiology and may be caused by other infections (such as TORCH infections) during pregnancy, as well as chromosomal disorders, exposure to environmental toxins and metabolic diseases [22, 23] . Congenital toxoplasmosis [24] , syphilis [25] , herpes simplex virus [26] and rubella [27, 28] may affect the central nervous system and cause neurologic deficits. Out of all of the cases in this study in which subependymal cysts were observed, only one pregnant woman had a reagent toxoplasmosis IgM result and a newborn who was ZIKV RT-PCR positive in the umbilical cord blood. Among those with vasculopathy, the only infection identified was that of ZIKV. These factors lead us to believe that ZIKV can be the cause of neurologic abnormalities. Knowing the cause of these issues is an important tool for prevention.
Because this is a descriptive study, a control group of women with no infection was not defined. A limitation presented by this study was the lack of data in some variables. The data were collected by the attending physician on the basis of a preestablished record, although it was not always completely filled out. The clinical spectrum observed in our newborns differed from those reported in other studies. Lenticulostriate vasculopathy, subependymal cysts, auditory disorder and chorioretinitis were the main outcomes observed, and there were no cases of macular hypoplasia, microcephaly or abnormal neurologic test results after birth. These findings showed that the symptoms of congenital Zika syndrome might be broader than originally thought. The link to ZIKV may not be clearly established nor excluded. In some cases, the only infectious agent detected was ZIKV. In cases where other infectious agents were identified by serologic tests, the clinical findings were not usually related to them.
In conclusion, our study highlights the importance of ZIKV infection in all trimesters of gestation. Brain abnormalities other than microcephaly, intracerebral calcifications or severe outcomes detected by imaging examinations during pregnancy may occur, reflecting the marked heterogeneity of exposure to ZIKV during pregnancy. Adverse outcomes were mild or nonexistent in our newborns, but their occurrence may affect neurologic development, thus having an important negative impact on the patient specifically and on the population more generally. These impacts may only be measured some years after birth. This study provides additional evidence of the association between congenital ZIKV infection and certain foetal outcomes, and it contributes to a better understanding in the pathogenesis of birth defects caused by ZIKV. 
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